In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG.

Proceedings of the National Academy of Sciences of the United States of America
Michael B OttenederLawrence J Marnett

Abstract

3-(2-Deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin-10(3H)-one (M1dG) is a DNA adduct arising from the reaction of 2-deoxyguanosine with the lipid peroxidation product, malondialdehyde, or the DNA peroxidation product, base propenal. M1dG is mutagenic in bacteria and mammalian cells and is present in the genomic DNA of healthy human beings. It is also detectable, albeit at low levels, in the urine of healthy individuals, which may make it a useful biomarker of DNA damage linked to oxidative stress. We investigated the possibility that the low urinary levels of M1dG reflect metabolic conversion to derivatives. M1dG was rapidly removed from plasma (t(1/2) = 10 min) after i.v. administration to rats. A single urinary metabolite was detected that was identified as 6-oxo-M1dG by MS, NMR spectroscopy, and independent chemical synthesis. 6-Oxo-M1dG was generated in vitro by incubation of M1dG with rat liver cytosols, and studies with inhibitors suggested that xanthine oxidase and aldehyde oxidase are involved in the oxidative metabolism. M1dG also was metabolized by three separate human liver cytosol preparations, indicating 6-oxo-M1dG is a likely metabolite in humans. This represents a report of the oxidative metabolism...Continue Reading

References

Jul 1, 1992·Chemical Research in Toxicology·D E Shuker, P B Farmer
Nov 1, 1986·Chemico-biological Interactions·H Autrup, T Seremet
Jul 1, 1966·Biochemical Pharmacology·G B ElionG H Hitchings
Oct 26, 1995·Biochemical Pharmacology·S K RoyM E Dolan
Sep 14, 1993·European Journal of Pharmacology·Y OsadaK Komoriya
Apr 25, 1997·The Journal of Biological Chemistry·K A JohnsonL J Marnett
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·S P FinkL J Marnett
Aug 8, 1997·The Journal of Biological Chemistry·K B Beckman, B N Ames
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·P C DedonL J Marnett
Feb 25, 2000·Chemical Research in Toxicology·N C Schnetz-BoutaudL J Marnett
Feb 26, 2000·Carcinogenesis·L J Marnett
Nov 18, 2000·Chemical Research in Toxicology·N Schnetz-BoutaudL J Marnett
Mar 6, 2003·The Journal of Clinical Investigation·Lawrence J MarnettJames D West
Jul 23, 2003·Chemical Research in Toxicology·Michael PollackIan A Blair
Nov 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Laurie A VanderVeenLawrence J Marnett
Jan 8, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·R Scott Obach
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·James E Klaunig, Lisa M Kamendulis
Mar 3, 2004·Archives of Biochemistry and Biophysics·Peter C Dedon, Steven R Tannenbaum
Dec 8, 2004·Cancer Detection and Prevention·Helmut Bartsch, Jagadeesan Nair
Nov 12, 2005·Nucleic Acids Research·Yo-Chan JeongJames A Swenberg

❮ Previous
Next ❯

Citations

Dec 30, 1998·Trends in Biochemical Sciences·L Aravind, E V Koonin
Jun 28, 2012·Pharmacogenetics and Genomics·Chung-Ying K ChenLee-Ho Wang
Nov 11, 2009·Journal of Clinical Biochemistry and Nutrition·Marcus S CookeMark D Evans
Jan 7, 2011·Journal of Nucleic Acids·Simon Wan Chan, Peter C Dedon
Aug 1, 2007·Biomarkers in Medicine·Peter C DedonBo Pang
Mar 4, 2014·Journal of Photochemistry and Photobiology. B, Biology·Joshua D WilliamsGeorg T Wondrak
Mar 15, 2008·Redox Report : Communications in Free Radical Research·Perumal SubramanianDaniel P Cardinali
Aug 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Watthanachai JumpathongPeter C Dedon
Jun 13, 2008·Toxicology and Applied Pharmacology·Witold M Winnik, Kirk T Kitchin
Mar 10, 2011·International Journal of Cancer. Journal International Du Cancer·Pallavi Lonkar, Peter C Dedon
Jan 11, 2007·Free Radical Biology & Medicine·Liuji ChenElla W Englander
Oct 21, 2014·Photochemistry and Photobiology·Jean CadetJean-Luc Ravanat
Jul 8, 2014·Oxidative Medicine and Cellular Longevity·Antonio AyalaSandro Argüelles
Jan 22, 2008·Nucleosides, Nucleotides & Nucleic Acids·Jozsef SzekelyCarmelo J Rizzo
Feb 14, 2018·Nucleic Acids Research·Orrette R WauchopeLawrence J Marnett
Oct 12, 2007·Physiological Reviews·A J HulbertW A Buttemer
Feb 14, 2021·Redox Biology·Mu-Rong ChaoMarcus S Cooke
Jan 10, 2009·Biochemistry·Charles G KnutsonLawrence J Marnett
Dec 7, 2007·Chemical Research in Toxicology·Peter C Dedon
Oct 16, 2015·Chemical Research in Toxicology·Orrette R WauchopeLawrence J Marnett
Apr 21, 2012·The Journal of Organic Chemistry·Lawrence J Marnett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.